Bessemer Group
PRCT icon

Bessemer Group’s Procept Biorobotics PRCT Stock Holding History

Bessemer Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,230
Closed -$281K – 2617
2026
Q1 		$281K Sell
11,230
-27,500
-71% -$775K ﹤0.01% 1312
2025
Q4 		$1.22M Buy
38,730
+13,800
+55% +$458K ﹤0.01% 915
2025
Q3 		$890K Buy
24,930
+6,595
+36% +$301K ﹤0.01% 686
2025
Q2 		$1.06M Buy
18,335
+7,435
+68% +$420K ﹤0.01% 629
2025
Q1 		$635K Buy
10,900
+3,665
+51% +$250K ﹤0.01% 815
2024
Q4 		$583K Sell
7,235
-2,570
-26% -$220K ﹤0.01% 856
2024
Q3 		$786K Sell
9,805
-7,900
-45% -$561K ﹤0.01% 821
2024
Q2 		$1.08M Sell
17,705
-3,320
-16% -$197K ﹤0.01% 648
2024
Q1 		$1.04M Buy
21,025
+150
+0.7% +$7.14K ﹤0.01% 671
2023
Q4 		$874K Buy
20,875
+5,160
+33% +$176K ﹤0.01% 687
2023
Q3 		$516K Buy
+15,715
New +$536K ﹤0.01% 785

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bessemer Group's PRCT Position: Q2 2026 in Review

Bessemer Group sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 11,230 shares — an estimated $281K sold.

Bessemer Group first reported a position in PRCT in Q3 2023 and held it in 11 quarters. The position peaked at $1.22M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Bessemer Group reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Bessemer Group sold 11,230 Procept Biorobotics shares in Q2 2026, an estimated $281K.
  • Bessemer Group first reported a position in Procept Biorobotics in Q3 2023 and held it in 11 quarters.
  • Bessemer Group's Procept Biorobotics position peaked at $1.22M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.